.svg)
SVRN was founded to address the disparity between the growing productivity of biomedical R&D and the diminishing efficiency of the financial and commercial infrastructure supporting biomedical innovation.
Technology and collaboration tools
Accessibility of information and resources to compile and analyze data can lower barriers to entry.
Non-dilutive funding solutions
Access to capital through mechanisms royalty or revenue financing can advance priority development activities without ceding leadership control.
Strategic licensing and partnerships
Expanding the reach of intellectual property can maximize its potential and create the most potential paths to patients.
SVRN’s Research Portal showcases early-stage biopharma research with the goal of promoting transparency, and allowing innovators and supporters to interact in a novel approach to collaborative drug development.
Current Drug Market Figures
Average cost to bring a drug to market.
Biotechs seeking funding across the globe.
Private capital deployed in 2023 to purchase drug royalties.
Clinical studies registered globally in 2024.
SVRN aims to find solutions to accelerate and protect the return of value created by the innovation ecosystem, propelling scientific progress aligned to public interest and needs.
Community
Follow our project, share ideas, and get involved in discussions and events. #joinourcommunity
Book a call with us
Innovator
Join our network of biotech innovators seeking visibility for their work and access to support. Apply to be listed in our beta marketplace of research and development projects. #joinsvrn
Book a call with us
Investor
Looking for opportunities to support biomedical innovation? We are constantly growing our network of investors seeking to advance drug development by connecting with and empowering innovators. #investinscience
Book a call with us
With over 30 years of combined experience, our founding team is dedicated to accelerating innovation and ensuring life-changing innovations are accessible to patients around the world.
❝SVRN is composed of a core team and community passionate about offering long-term solutions to empower biomedical innovation and protect the return ecosystem that fuels future innovations for decades to come.
Max Hunt
Partner, Trinity Life Sciences
- • 12+ years experience in life science consulting
- • Work across US and global markets with 16 of top 20 biopharma companies
- • Thought leader in drug pricing and market access for innovative medicines
Hui Huang, PHD
Co-Founder, Etheros Health Data Foundation / CEO, CSD Partners
- • 20+ years experience in biopharma; former Global Vice President of Takeda Oncology
- • 16 research publications across key HTA markets
- • Deep experience leading assets from pre-clinical through post-commercialization stages
A comprehensive FAQ section that provides quick and easy access to all the information you need to understand our product.
How are new marketplace listings vetted?
SVRN team members vet potential IP listings from potential biotechs and partnered tech transfer offices. Researchers are welcome to reach out to SVRN directly to be listed on our platform.
What is the benefit of listing on SVRN?
The SVRN marketplace allows biomedical research and development projects to gain visibility to enable connections to partners, investors, and other interested parties. Community engagement also allows for the open sharing of knowledge to guide decision-making.
Can details of my research project be anonymized?
Yes, SVRN intends to promote visibility of research projects while appreciating the importance of confidentiality on various aspects of the work. The extent of transparency of the listing is fully customizable.
